Home » Pharma News » Marksans Pharma rushes on USFDA nod for Loratadine

Marksans Pharma rushes on USFDA nod for Loratadine

 Marksans Pharma rushes  on USFDA nod for Loratadine

has moved higher by 12% to Rs 53.55 on the BSE after the company announced that it has got US drug regulator nod for liquid filed capsules 10 mg.

“The US Food & Drug Administration (USFDA) has granted approval for an Abbreviated New Drug Application (ANDA) for liquid filed capsules 10 mg,”said in a press release.

liquid filed capsules 10 mg is therapeutically equivalent to the reference listed drug Claritin Liqui-Gels Capsules 10 mg of Bayer Healthcare LLC.

is an antihistamine that reduces the effects of natural chemical histamine in the body. is used to treat sneezing, runny nose, watery eyes, hives, skin rash, itching, and other cold or allergy symptoms.

 

Read more @ http://vivanls.com/#

 

Thanks for the comment

BIGTheme.net • Free Website Templates - Downlaod Full Themes
Social Media Auto Publish Powered By : XYZScripts.com